Unknown PHASE1 INTERVENTIONAL 7-arm NCT05114226

A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury

Clinical Professor

Sponsor: West China Second University Hospital

Updated 5 times since 2021 Last updated: Feb 25, 2022 Started: Mar 1, 2022 Primary completion: Nov 1, 2023 Completion: Jan 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Radiation-Induced Dermatitis and is currently ongoing. West China Second University Hospital leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
Mar 2022 — Mar 2024 [monthly]

Not Yet Recruiting PHASE1
Dec 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

West China Second University Hospital

Data source: West China Second University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China